ChinaBio Today -- Shanghai ChemPartner Co., Ltd. and ELARA Pharmaceuticals will extend their drug discovery collaboration to include DMPK, pharmacology and toxicology for ELARA’s lead oncology programs. The two companies will jointly design and execute a drug screening cascade for ELARA’s Hypoxia Signaling inhibitor program.
